Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (231-240 of 320) with videos related to

Pageof 32
Sort By:
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
BMC Cancer|March 29, 2018
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkersCécile Le Page, Kurosh Rahimi, Martin Köbel, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasMichael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
Pageof 32

Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
BMC Cancer|March 29, 2018
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkersCécile Le Page, Kurosh Rahimi, Martin Köbel, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasMichael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
Pageof 32